Evidence map›Paper›PMID 28960731›Full record

ArticleAngewandte Chemie (International ed. in English)2017

Covalent Lectin Inhibition and Application in Bacterial Biofilm Imaging.

Stefanie Wagner, Dirk Hauck, Michael Hoffmann, Roman Sommer, Ines Joachim, Rolf Müller, Anne Imberty, Annabelle Varrot, Alexander Titz

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Glyco-Nanogels for Modulating Pseudomonas aeruginosa Biofilm.Macromolecular rapid communications · 2026
    Article
  2. Article
  3. Covalent Activation of the C-type Lectin DC-SIGN.Angewandte Chemie (International ed. in English) · 2026
    Article
  4. Mechanisms ofMedicina (Kaunas, Lithuania) · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Lectin-Targeted Prodrugs Activated byJournal of medicinal chemistry · 2022
    Article
  14. Discovery ofJournal of medicinal chemistry · 2022
    Article
  15. Review
  16. Targeting the Central Pocket of the Pseudomonas aeruginosa Lectin LecA.Chembiochem : a European journal of chemical biology · 2022
    Article
  17. Synthesis ofTetrahedron letters · 2021
    Article
  18. Non-Carbohydrate Glycomimetics as Inhibitors of Calcium(II)-Binding Lectins.Angewandte Chemie (International ed. in English) · 2021
    Article
  19. Article
  20. International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stefanie WagnerChemical Biology of Carbohydrates, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123, Saarbrücken, Germany.
Dirk HauckChemical Biology of Carbohydrates, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123, Saarbrücken, Germany.
Michael HoffmannDeutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-Braunschweig, Germany.
Roman SommerChemical Biology of Carbohydrates, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123, Saarbrücken, Germany.ORCID 0000-0003-0592-0810
Ines JoachimChemical Biology of Carbohydrates, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123, Saarbrücken, Germany.
Rolf MüllerDeutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-Braunschweig, Germany.
Anne ImbertyUniversité Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, France.ORCID 0000-0001-6825-9527
Annabelle VarrotUniversité Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, France.ORCID 0000-0001-6667-8162
Alexander TitzChemical Biology of Carbohydrates, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123, Saarbrücken, Germany.ORCID 0000-0001-7408-5084

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilm formation by pathogenic bacteria is a hallmark of chronic infections. In many cases, lectins play key roles in establishing biofilms. The pathogen Pseudomonas aeruginosa often exhibiting various drug resistances employs its lectins LecA and LecB as virulence factors and biofilm building blocks. Therefore, inhibition of the function of these proteins is thought to have potential in developing "pathoblockers" preventing biofilm formation and virulence. A covalent lectin inhibitor specific to a carbohydrate binding site is described for the first time. Its application in the LecA-specific in vitro imaging of biofilms formed by P. aeruginosa is also reported.

Indexed as

Adhesins, BacterialBinding SitesBiofilmsCarbohydratesCrystallography, X-RayDrug DesignEpoxy CompoundsLectinsPseudomonas aeruginosaVirulence FactorsAdhesins, BacterialCarbohydratesEpoxy CompoundsLecA protein, bacteriaLectinsVirulence FactorsbiofilmscarbohydratesglycomimeticslectinsPseudomonas aeruginosa

Identifiers

PMID28960731
PMCPMC5767747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.